Clinical Trial Update: Speech Entrainment Treatment for People With Aphasia [NA]

View source ↗

Summary

A completed clinical trial (NCT05687994) sponsored by Albert Einstein Healthcare Network studied speech entrainment treatment for acquired aphasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphasia

Snippet

Sponsor: Albert Einstein Healthcare Network | Conditions: Aphasia, Acquired | NA | Status: COMPLETED